FDAFDA · Food and drugs·Recall number D-0575-2023
Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05
Published May 24, 2023 · Recall initiated: April 11, 2023
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Malformed crimped collar seal
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- ADMELOG
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot # 3F497B, EXP 12-31-2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.